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  Estramustine phosphate （Estracyt） was administered to 15 patients with prostatic carcinoma
and its therapeutic effects were followed．
  1． We were able to evaluate IO patients， in primary treatment for 11 patients． Good ciinical
response was obtained in these 10 patients．
  2． Good clinical response was obtained in one of 4 patients having resistance to hormone therapy．
  3． Gynecomastia and gastro－intestinal symptom were observed frequently and hepatotoxicity，
anemia， thrombocytopenia and massive edema were observed in one case respectively．
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つぎに副作用についてみるとTable 4に示すように
Table 4．副 作 用
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